发明名称 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF
摘要 <p>It is intended to compounds having a p38MAP kinase inhibitory activity. Because of having a p38MAP kinase inhibitory activity, compounds represented by the general formula (I), salts thereof, N-oxide derivatives thereof, solvates thereof or prodrugs thereof are useful in preventing and/or treating diseases the occurrence or worsening of the pathological conditions of which seemingly relates to abnormal production of cytokines such as inflammatory cytokines and chemokines or overresponses thereto, that is, cytokine-mediated diseases such as inflammatory diseases, respiratory diseases, circulatory diseases and bone diseases. General formula (I) [Chemical formula 1] (I) [wherein each symbol is as defined in the description.]</p>
申请公布号 WO2005105743(A1) 申请公布日期 2005.11.10
申请号 WO2005JP08065 申请日期 2005.04.27
申请人 ONO PHARMACEUTICAL CO., LTD.;NAKAI, HISAO;YAMAMOTO, SHINGO;SUGITANI, MASAFUMI 发明人 NAKAI, HISAO;YAMAMOTO, SHINGO;SUGITANI, MASAFUMI
分类号 A61K31/438;A61K31/4418;A61K31/443;A61K31/4439;A61K31/444;A61K31/4545;A61K31/496;A61K45/00;A61K31/506;A61K31/5377;A61K31/55;A61K45/06;A61P3/00;A61P5/00;A61P9/00;A61P11/00;A61P13/00;A61P19/02;A61P19/08;A61P25/28;A61P29/00;A61P31/00;A61P35/00;A61P43/00;C07D211/76;C07D211/82;C07D211/86;C07D213/64;C07D213/75;C07D213/89;C07D401/12;C07D401/14;C07D405/12;C07D413/12;C07D417/12;C07D471/10;(IPC1-7):C07D211/82;A61K31/441;A61K31/454;A61K31/537 主分类号 A61K31/438
代理机构 代理人
主权项
地址